Delan Li

511 total citations
13 papers, 195 citations indexed

About

Delan Li is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Delan Li has authored 13 papers receiving a total of 195 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Delan Li's work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (5 papers) and Cancer therapeutics and mechanisms (4 papers). Delan Li is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (5 papers) and Cancer therapeutics and mechanisms (4 papers). Delan Li collaborates with scholars based in China, Hong Kong and Canada. Delan Li's co-authors include Likun Chen, Fang Wang, Xue Hou, Kenneth K.W. To, Liwu Fu, Qiuxiang Ou, Ke Yang, Yifan Chen, Yang Shao and Qianqian Deng and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and BMC Medicine.

In The Last Decade

Delan Li

12 papers receiving 193 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Delan Li China	7	134	118	69	39	23	13	195
Daniele Presti Italy	7	153 1.1×	75 0.6×	49 0.7×	43 1.1×	16 0.7×	17	223
Pei Jye Voon Malaysia	7	118 0.9×	127 1.1×	51 0.7×	20 0.5×	6 0.3×	28	199
Gloria Borra Italy	6	132 1.0×	130 1.1×	58 0.8×	34 0.9×	13 0.6×	14	213
Yu Yu China	5	139 1.0×	60 0.5×	32 0.5×	31 0.8×	6 0.3×	6	197
Kyoung‐Joo Jenny Park United States	7	85 0.6×	51 0.4×	59 0.9×	39 1.0×	10 0.4×	7	179
Masafumi Sata Japan	10	202 1.5×	194 1.6×	51 0.7×	12 0.3×	9 0.4×	25	283
Kato Kambartel Germany	4	104 0.8×	150 1.3×	59 0.9×	41 1.1×	7 0.3×	6	184
Sandeep H. Mashru United States	4	71 0.5×	55 0.5×	26 0.4×	21 0.5×	11 0.5×	7	96
Coralia Bueno Spain	8	111 0.8×	78 0.7×	36 0.5×	63 1.6×	17 0.7×	22	170
Tetsuji Terazawa Japan	9	96 0.7×	84 0.7×	22 0.3×	32 0.8×	4 0.2×	41	169

Countries citing papers authored by Delan Li

Since Specialization

Citations

This map shows the geographic impact of Delan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Delan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Delan Li more than expected).

Fields of papers citing papers by Delan Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Delan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Delan Li. The network helps show where Delan Li may publish in the future.

Co-authorship network of co-authors of Delan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Delan Li. A scholar is included among the top collaborators of Delan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Delan Li. Delan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Liu, Yongzhong, et al.. (2023). Prognostic Values and Prospective Pathway Signaling of miR-25 in Non-Small Cell Lung Cancer: A Bioinformatics Analysis Based on Gene Expression Omnibus. Science of Advanced Materials. 15(1). 126–135.

Zhao, Yi, Kai Liu, Yajie Xiao, et al.. (2022). The mechanism of lncRNAs in the crosstalk between epithelial-mesenchymal transition and tumor microenvironment for early colon adenocarcinoma based on molecular subtyping. Frontiers in Genetics. 13. 997739–997739. 3 indexed citations

Li, Meichen, Jing Chen, Na Wang, et al.. (2022). Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor responses in non-small cell lung cancer patients with brain metastases: a prospective cohort study (GASTO 1028). BMC Medicine. 20(1). 398–398. 18 indexed citations

Li, Meichen, Xue Hou, Jing Chen, et al.. (2022). Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and to better predict intracranial tumor response in patients with non–small cell lung cancer with brain metastases: A prospective cohort study.. Journal of Clinical Oncology. 40(16_suppl). 2023–2023. 1 indexed citations

Fang, Wenfeng, Jianwen Li, Delan Li, et al.. (2021). Impact of STAT1 polymorphisms on crizotinib-induced hepatotoxicity in ALK-positive non-small cell lung cancer patients. Journal of Cancer Research and Clinical Oncology. 147(3). 725–737. 12 indexed citations

Chen, Xinru, Xue Hou, Xiao-Xiao Dinglin, et al.. (2020). Treatment Patterns and Survival Outcomes of Non-Small Cell Lung Cancer Patients Initially Diagnosed With Brain Metastases in Real-World Clinical Practice. Frontiers in Oncology. 10. 581729–581729. 7 indexed citations

Wang, Fang, Delan Li, Zongheng Zheng, et al.. (2020). Reversal of ABCB1-related multidrug resistance by ERK5-IN-1. Journal of Experimental & Clinical Cancer Research. 39(1). 50–50. 21 indexed citations

Hou, Xue, Delan Li, Ke Sai, et al.. (2020). Management of Non–Small-Cell Lung Cancer Patients Initially Diagnosed With 1 to 3 Synchronous Brain-Only Metastases: A Retrospective Study. Clinical Lung Cancer. 22(1). e25–e34. 11 indexed citations

Yang, Ke, Yifan Chen, Kenneth K.W. To, et al.. (2020). Correction: Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo. Experimental & Molecular Medicine. 52(6). 989–990. 3 indexed citations

10.

Li, Meichen, Delan Li, Xue Hou, et al.. (2020). Utilizing phenotypic characteristics of metastatic brain tumors to predict the probability of circulating tumor DNA detection from cerebrospinal fluid.. Journal of Clinical Oncology. 38(15_suppl). 2507–2507. 1 indexed citations

11.

Wang, Hongsheng, Qiuxiang Ou, Delan Li, et al.. (2019). Genes associated with increased brain metastasis risk in non–small cell lung cancer: Comprehensive genomic profiling of 61 resected brain metastases versus primary non–small cell lung cancer (Guangdong Association Study of Thoracic Oncology 1036). Cancer. 125(20). 3535–3544. 77 indexed citations

12.

Yang, Ke, Yifan Chen, Kenneth K.W. To, et al.. (2017). Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo. Experimental & Molecular Medicine. 49(3). e303–e303. 40 indexed citations

13.

Li, Delan, et al.. (2016). Long‐lasting response to third‐line crizotinib treatment in a patient with non‐small cell lung cancer with brain metastases and poor performance status. Thoracic Cancer. 7(5). 619–622. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact